- Investing Ideas
- Japanese Pharmaceuticals & Biotech Undervalued over 20% based on DCF
Japanese Pharmaceuticals & Biotech Undervalued over 20% based on DCF
Results
13
Companies which are undervalued more than 20% based on the Discounted Cash Flow valuation.
13 companies
Chugai Pharmaceutical
Market Cap: JP¥14.4t
Engages in the research, development, manufacture, sale, importation, and exportation of pharmaceuticals in Japan and internationally.
4519
JP¥8,775.00
7D
-4.6%
1Y
30.6%
Daiichi Sankyo Company
Market Cap: JP¥5.1t
Manufactures and sells pharmaceutical products in Japan, the United States, Europe, and internationally.
4568
JP¥2,806.50
7D
-2.8%
1Y
-14.7%
Astellas Pharma
Market Cap: JP¥4.7t
Manufactures, markets, imports, and exports pharmaceuticals in Japan and internationally.
4503
JP¥2,600.00
7D
-0.02%
1Y
95.0%
Shionogi
Market Cap: JP¥3.0t
Engages in the research, development, manufacture, and distribution of pharmaceuticals, diagnostic reagents, and medical devices in Japan and internationally.
4507
JP¥3,478.00
7D
-1.9%
1Y
51.4%
Eisai
Market Cap: JP¥1.5t
Engages in the research and development, manufacture, sale, and import and export of pharmaceuticals in India.
4523
JP¥5,163.00
7D
2.6%
1Y
38.9%
Kyowa Kirin
Market Cap: JP¥1.4t
Engages in the research, development, manufacturing, and marketing of pharmaceuticals in Japan, the Americas, Europe, Asia, and internationally.
4151
JP¥2,621.00
7D
-0.4%
1Y
23.6%
Ono Pharmaceutical
Market Cap: JP¥1.2t
Produces, purchases, and sells pharmaceuticals and diagnostic reagents worldwide.
4528
JP¥2,545.00
7D
0.5%
1Y
49.9%
Santen Pharmaceutical
Market Cap: JP¥610.2b
Engages in the research and development, manufacturing, and marketing of pharmaceuticals and medical devices in Japan, China, Asia, Europe, the Middle East, Africa, and internationally.
4536
JP¥1,897.00
7D
4.2%
1Y
35.1%
Hisamitsu Pharmaceutical
Market Cap: JP¥423.6b
Manufactures and sells pharmaceuticals in Japan.
4530
JP¥6,043.00
7D
0.07%
1Y
51.7%
Sawai Group Holdings
Market Cap: JP¥260.1b
Together with subsidiaries, engages in the research and development, manufacture, and marketing of generic pharmaceuticals.
4887
JP¥2,252.50
7D
0.7%
1Y
17.6%
Kissei Pharmaceutical
Market Cap: JP¥197.7b
Researches, develops, manufactures, and sells pharmaceutical products primarily in Japan.
4547
JP¥4,770.00
7D
-2.0%
1Y
29.8%
KYORIN Pharmaceutical
Market Cap: JP¥97.4b
Through its subsidiaries, researches and develops, manufactures, and sells ethical and generic drugs in Japan and internationally.
4569
JP¥1,695.00
7D
-0.06%
1Y
18.7%
Daito PharmaceuticalLtd
Market Cap: JP¥41.8b
Engages in the manufacture and sale of pharmaceutical products in Japan and internationally.
4577
JP¥1,432.00
7D
-1.0%
1Y
32.8%